Abstract
1346P Efficacy and safety of high dose furmonertinib combined with intrathecal injection in EGFR-mutated advanced NSCLC patients with LM progressed on osimertinib
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have